🇺🇸 FDA
Pipeline program

GTX-104

GTX-104-002

Phase 1 small_molecule completed

Quick answer

GTX-104 for Aneurysmal Subarachnoid Hemorrhage is a Phase 1 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Aneurysmal Subarachnoid Hemorrhage
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials